Literature DB >> 21275178

[Key issues on the clinical pathway development: a view from Chinese medicine and integrative medicine].

Da-Rong Wu1, Luo-Jing Zhou, Si-Cheng Wang.   

Abstract

Comparing with the Western medicine, the clinical pathway development of Chinese medicine (CM)/integrative medicine (IM), on one hand, should follow the basic principles of general clinical pathway; on the other and prior hand, it ought to coordinate with the rule of CM, and display sufficiently the advantages of CM based upon the evidences. Several key issues which may be encountered in the development and the relevant strategies were introduced in this paper.

Mesh:

Year:  2010        PMID: 21275178

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

Review 1.  [Development of an internet-based clinical pathway exemplified by the fibromyalgia syndrome].

Authors:  M Noll-Hussong
Journal:  Schmerz       Date:  2012-04       Impact factor: 1.107

2.  Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.

Authors:  Kunyan Zhou; Jing Zhang; Liangzhi Xu; Chi Eung Danforn Lim
Journal:  Cochrane Database Syst Rev       Date:  2021-06-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.